217
Participants
Start Date
March 27, 2025
Primary Completion Date
March 31, 2027
Study Completion Date
March 31, 2030
Recorded interview
A recorded clinical interview, transcribed verbatim and blinded analyzed
Clinical scales
Answering to clinical scales : PANSS (Positive and Negative Syndrome Scale); BPRS (Brief Psychiatric Rating Scale); CDSS (Calgary Depression Scale for Schizophrenia); MADRS (Montgomery-Åsberg Depression Rating Scale); Altman; YMRS (Young Mania Rating Scale); GAF (Global Assessment of Functioning); SF-36 (36-Item Short Form Survey); CGI-S (Clinical Global Impression Scale) et CGI-I (CGI-Improvement)
Blood sample
Blood collection of inflammatory markers (IL-1, sIL-2R, IL-4, IL-6, IL-8 and TNF levels) and 2 EDTA tubes and 2 dry tubes for biological collection (plasma bank and serum bank). This blood sample will be taken during routine sampling.
NOT_YET_RECRUITING
Dr Sonia MARSELLA, Quimper
RECRUITING
Dr Florian STEPHAN, Brest
NOT_YET_RECRUITING
Dr Dominique DRAPIER, Rennes
NOT_YET_RECRUITING
Dr Vincent CAMUS, Tours
NOT_YET_RECRUITING
Dr Anne SAUVAGET, Nantes
NOT_YET_RECRUITING
Dr Bénédicte GOHIER, Angers
University Hospital, Brest
OTHER